Simvastatin: strengths, interaction limits and muscle side effects
Simvastatin is a statin that lowers LDL cholesterol and is used to reduce cardiovascular risk in people with heart or artery disease or with diabetes. Its product information gives it as a single dose in the evening and lists a number of medicines that must not be taken with it or that cap its dose. This page sets out the strengths authorised in Malta, the doses, those interactions, the side effects and how a request is assessed.
Simvastatin products authorised in Malta
Simvastatin belongs to the statins, or HMG-CoA reductase inhibitors. In the Medicines Authority register, seven authorised products contain simvastatin as the only active substance: Simvacor 10 mg (MA122/02401), Simvastatin Crescent 10, 20 and 40 mg (MA1317/01401 to MA1317/01403) and Simvastatina Arena 10, 20 and 40 mg (AA1161/01504, AA1161/01503 and AA1161/01505). All are film-coated tablets and all are classified as prescription-only medicines (POM). Other simvastatin authorisations in the register are recorded as withdrawn. The register lists no authorised national combination of simvastatin with another substance, while Cholib, a fixed combination with fenofibrate, is authorised in the EU through the central procedure and is subject to medical prescription.
When the substance and the product share a name, it is easy to assume that every pack is the same. The strength printed on the pack is what differs, and with simvastatin the strength is exactly what other medicines limit. If your tablets look different after a new supply, check the strength against your prescription and ask the pharmacist if they do not match.
What simvastatin is used for
The summary of product characteristics (SmPC) of Simvastatin Crescent lists three uses (section 4.1). The first is primary hypercholesterolaemia or mixed dyslipidaemia, alongside diet, when diet and other non-drug measures such as exercise and weight reduction are not enough. The second is homozygous familial hypercholesterolaemia, alongside diet and other lipid-lowering treatments. The third is reducing cardiovascular death and illness in people with established atherosclerotic cardiovascular disease or diabetes, whether their cholesterol is normal or raised, together with correcting other risk factors.
The leaflet explains that, at too high a level, cholesterol can settle in the artery walls and build up until it blocks a blood vessel. Whether you need a statin, and which one, depends on your blood test together with the rest of your risk and the other medicines you take. Our guide to high cholesterol explains the blood test.
Why simvastatin is taken in the evening
The SmPC gives simvastatin as a single dose in the evening (section 4.2), and the leaflet tells you to take the tablets in the evening, with or without food. The leaflet also explains that food supplies only a small part of the body's cholesterol, while the liver makes almost all of it, mostly at night.
After you swallow it, simvastatin, an inactive lactone, is converted in the liver into its active form, which blocks HMG-CoA reductase, the enzyme that controls an early, rate-limiting step in the making of cholesterol (SmPC, section 5.1). The SmPC describes the result as less production and more breakdown of LDL, with a substantial fall in apolipoprotein B, a moderate rise in HDL cholesterol and a fall in triglycerides.
If you also take a bile acid sequestrant, the SmPC asks for simvastatin to be taken more than 2 hours before or more than 4 hours after it. Follow the instructions on your own pack.
Doses in the summary of product characteristics
The dosage range in the SmPC is 5 to 80 mg a day, taken as a single dose in the evening, with changes made at intervals of not less than 4 weeks (section 4.2). The 80 mg dose is recommended only for people with severe hypercholesterolaemia at high risk of cardiovascular complications who have not reached their treatment goals on lower doses, because the risk of muscle damage is higher at that dose. You stay on a cholesterol-lowering diet during treatment.
No dose change is needed because of age or for moderate kidney impairment; in severe kidney impairment, doses above 10 mg a day are considered carefully. Several medicines cap the dose, as the section on interactions below explains.
If you miss a dose, the leaflet says to take it as soon as possible, unless it is almost time for the next one, and never to take a double dose. Keep taking the tablets for as long as the doctor has asked; if you want to stop, talk to the doctor or the pharmacist, because your cholesterol may rise again.
| Situation | Dose in the SmPC |
|---|---|
| Primary hypercholesterolaemia | Usually 10 to 20 mg in the evening to start; 20 to 40 mg if LDL needs to fall by more than 45% |
| Homozygous familial hypercholesterolaemia | 40 mg in the evening to start, together with other lipid-lowering treatments |
| Cardiovascular prevention in people at high risk | Usually 20 to 40 mg in the evening |
| Heterozygous familial hypercholesterolaemia, ages 10 to 17 | 10 mg in the evening to start; usual range 10 to 40 mg, maximum 40 mg |
| Highest dose | 80 mg, only in severe hypercholesterolaemia with a high cardiovascular risk |
Medicines that must not be taken with simvastatin, and those that cap the dose
Simvastatin is broken down by the liver enzyme CYP3A4 and carried by the transport protein OATP1B1, so medicines that block them raise its level and the risk of muscle damage (SmPC, section 4.5). The SmPC divides these medicines into those that must not be combined with simvastatin and those that limit its dose; the table sums up the main groups. If you take amlodipine for blood pressure, see also our page on amlodipine.
If a potent CYP3A4 inhibitor cannot be avoided, for example a course of clarithromycin, the SmPC says simvastatin must be suspended for the duration of that treatment, and an alternative statin may be considered. With fusidic acid given by mouth or by injection, the statin is stopped for the whole course and restarted no sooner than 7 days after the last dose.
Other points from section 4.5: fluconazole and fenofibrate call for caution; colchicine with simvastatin has been linked with muscle problems in people with kidney impairment; rifampicin can reduce the effect of simvastatin; and with warfarin and other coumarin anticoagulants the INR is checked before starting and after any dose change.
Because the list is long, mention that you take simvastatin whenever any new medicine is prescribed, and ask the pharmacist to check your full list, including medicines bought without a prescription, food supplements and herbal products.
| Medicine | What the SmPC says |
|---|---|
| Itraconazole, ketoconazole, posaconazole, voriconazole | Contraindicated |
| Erythromycin, clarithromycin, telithromycin | Contraindicated |
| HIV protease inhibitors (for example nelfinavir), cobicistat, boceprevir, telaprevir, nefazodone | Contraindicated |
| Ciclosporin, danazol, gemfibrozil | Contraindicated |
| Other fibrates, except fenofibrate | Not more than 10 mg simvastatin a day |
| Amiodarone, amlodipine, diltiazem, verapamil | Not more than 20 mg simvastatin a day |
| Elbasvir, grazoprevir | Not more than 20 mg simvastatin a day |
| Lomitapide, in homozygous familial hypercholesterolaemia | Not more than 40 mg simvastatin a day |
| Fusidic acid | Not recommended; the statin is paused |
| Daptomycin | Pausing simvastatin is considered |
| Palbociclib, ribociclib | Not recommended, or to be avoided |
| Niacin (nicotinic acid) at 1 g a day or more | Rare cases of muscle problems; not recommended in Asian patients |
| Grapefruit juice | To be avoided |
Who should not take simvastatin
The SmPC lists the contraindications below (section 4.3). If one of them applies to you, tell the doctor before any decision about treatment.
- An allergy to simvastatin or to any other ingredient of the tablets.
- Active liver disease, or unexplained, persistent rises in liver enzymes (transaminases).
- Pregnancy and breast-feeding.
- Treatment with a potent CYP3A4 inhibitor, or with ciclosporin, danazol or gemfibrozil, as listed in the table above.
- In homozygous familial hypercholesterolaemia, lomitapide together with simvastatin above 40 mg a day.
Muscle problems and other warnings
Like other statins, simvastatin occasionally causes myopathy: muscle pain, tenderness or weakness with a marked rise in creatine kinase (CK), an enzyme released from damaged muscle. Myopathy sometimes takes the form of rhabdomyolysis, with or without acute kidney failure, and very rare deaths have occurred (SmPC, section 4.4). The risk depends on the dose: in the clinical studies described in the SmPC, myopathy became more frequent as the dose rose and was clearly most frequent at 80 mg a day, which is why that dose is reserved for the situation described above.
Everyone who starts simvastatin or has the dose increased should be told about this risk, and the leaflet asks you to contact the doctor immediately about unexplained muscle pain, tenderness or weakness. Severe muscle pain, especially with dark urine or feeling unwell, needs urgent medical help. In an emergency, call 112 or go to Accident and Emergency.
Before treatment, the SmPC recommends measuring CK in people aged 65 or over, in women, and in people with reduced kidney function, an uncontrolled underactive thyroid, a personal or family history of inherited muscle disorders, earlier muscle problems on a statin or a fibrate, or alcohol abuse. Caution and the lowest necessary dose are advised in Asian patients. Very rare cases of immune-mediated necrotising myopathy, with weakness that persists after stopping, have been reported.
Liver function tests are recommended before treatment and afterwards when clinically indicated, and simvastatin is used with caution if you drink substantial quantities of alcohol. The SmPC asks for it to be stopped for a few days before elective major surgery and when a major medical or surgical condition arises. Statins can raise blood sugar, and people at risk of diabetes are monitored; the SmPC states that this should not be a reason for stopping. Myasthenia gravis and interstitial lung disease have been reported with statins. The tablets contain lactose.
Care is also needed with digoxin and with anticoagulants of the coumarin type, where clotting tests may need checking more often around a dose change.
Side effects listed for simvastatin
In the clinical studies described in the SmPC, the Heart Protection Study compared simvastatin 40 mg with placebo over several years. The safety profiles were comparable, and about as many people stopped because of side effects in each group (section 4.8). Effects that occurred no more often than with placebo in the large trials, but have been reported, are classed in the SmPC as rare, which is why most effects in the table carry that label.
A hypersensitivity syndrome has been reported rarely, with features such as angioedema, a lupus-like syndrome, joint pain, hives, sensitivity to light, fever and breathlessness. Rare reports of memory loss, forgetfulness or confusion have been linked to statins, including simvastatin; the SmPC describes them as generally non-serious and reversible after stopping. Rises in HbA1c and fasting blood sugar have also been reported.
Get medical help without delay for yellowing of the skin or eyes, severe abdominal pain, a widespread rash, or swelling of the face or tongue with difficulty breathing. You can report a suspected side effect to the doctor or the pharmacist; the SmPC asks healthcare professionals to report suspected reactions to the Medicines Authority.
| Frequency in the SmPC | Side effects |
|---|---|
| Rare (up to 1 in 1,000 people) | Anaemia, headache, tingling, dizziness, nerve damage in the hands and feet, blurred vision, weakness |
| Rare, continued | Constipation, abdominal pain, wind, indigestion, diarrhoea, nausea, vomiting, pancreatitis, hepatitis or jaundice |
| Rare, continued | Rash, itching, hair loss, myopathy, rhabdomyolysis, muscle pain, muscle cramps, raised liver enzymes and CK |
| Very rare (up to 1 in 10,000 people) | Anaphylaxis, difficulty sleeping, memory impairment, liver failure, lichenoid skin eruptions, muscle rupture, breast enlargement in men |
| Not known | Depression, myasthenia gravis, ocular myasthenia, interstitial lung disease, tendon disorders, immune-mediated necrotising myopathy, erectile dysfunction |
Pregnancy and breast-feeding
Simvastatin is contraindicated in pregnancy and while breast-feeding (SmPC, sections 4.3 and 4.6). The leaflet asks women who could become pregnant not to take it unless they use a reliable form of contraception, and to stop it immediately and consult the doctor if they discover that they are pregnant. The SmPC notes that safety in pregnancy has not been established and that treatment must be suspended for the duration of the pregnancy or until it has been determined that you are not pregnant. Adolescent girls on simvastatin should be counselled on contraception.
Simvastatin compared with atorvastatin
Both are statins, but their product information differs in ways that matter in practice. The atorvastatin SmPC allows the dose at any time of day, and several medicines that rule out simvastatin call instead for a lower atorvastatin dose with monitoring; see our page on atorvastatin. Which statin suits you, and at what strength, is the doctor's decision, based on your results, your cardiovascular risk and your other medicines. The groups of cholesterol medicines are compared on our page on statins and cardiovascular risk.
How a request for simvastatin is assessed
You fill in a medical questionnaire about the medicine, your health and other medicines you take, and the doctor reviews your answers in writing. Give your full list of medicines, because with simvastatin the list decides the strength. If you already take simvastatin, it helps to have a recent lipid profile and a recent liver function result to hand. For a first prescription your answers need to show clear indications, because starting a statin depends on your overall cardiovascular risk.
If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. The doctor may ask you for test results, may recommend that you see a doctor in Malta, or may decline. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. Unexplained muscle pain and the other warning signs above need to be examined, not assessed in writing.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
What does it cost?
Two separate costs are involved. The button on this page shows the fee for the doctor's review, and the medicine itself is paid for at the pharmacy, which can tell you the price of your pack. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.
The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.
Who reviews your request?
Your request is reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta.
Is simvastatin prescription-only in Malta?
All seven authorised simvastatin products in the Medicines Authority register, Simvacor 10 mg and the 10, 20 and 40 mg tablets of Simvastatin Crescent and Simvastatina Arena, are classified as prescription-only medicines (POM). The doctor sets the strength, which also depends on the other medicines you take.
Why is simvastatin taken in the evening?
The SmPC gives simvastatin as a single dose in the evening, and the leaflet tells you to take it then. The leaflet explains that nearly all the body's cholesterol is made by the liver, mostly at night. Follow the instructions for your own pack.
What happens if I miss a dose of simvastatin?
The leaflet says to take the missed dose as soon as possible, unless it is almost time for the next one, in which case you skip it and carry on as usual. Do not take a double dose to make up for a forgotten one.
Can I drink grapefruit juice with simvastatin?
The SmPC and the leaflet say grapefruit juice should be avoided. Grapefruit juice blocks the enzyme that breaks simvastatin down. In studies described in the SmPC, large quantities raised the level of its active form considerably, and even one glass in the morning with simvastatin in the evening raised it.
Which medicines should not be taken with simvastatin?
The SmPC rules out itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, cobicistat, boceprevir, telaprevir, nefazodone, ciclosporin, danazol and gemfibrozil. With amiodarone, amlodipine, diltiazem or verapamil the dose is limited to 20 mg a day, and with fibrates other than fenofibrate to 10 mg.
What are the side effects of simvastatin?
In the large trials described in the SmPC, the safety profile of simvastatin 40 mg was comparable with placebo. The effects listed include headache, digestive complaints, muscle pain and cramps, rash and raised liver enzymes; rare but serious are myopathy and rhabdomyolysis, whose risk rises with the dose and with certain combinations.
Do I need to stop simvastatin before an operation?
The SmPC asks for simvastatin to be stopped for a few days before elective major surgery and when a major medical or surgical condition arises, and the leaflet says you may need to stop it for a short time if you are due to have an operation. Tell the surgeon or the hospital team that you take it.
Can a pharmacy in Malta dispense a prescription from a doctor in another EU country?
A prescription from a doctor in another EU country can be dispensed in Malta (Article 81(3) of the Medicines Act, Cap. 458) if the pharmacist can confirm the doctor's licence. The decision rests with the pharmacist, who may refuse. You need the printed document and photo identification with you at the pharmacy.
- Medicines Authority: Simvastatin Crescent 20 mg film-coated tablets (MA1317/01402), with summary of product characteristics and package leaflet
- Medicines Authority: Simvacor 10 mg film-coated tablets (MA122/02401)
- Medicines Authority: Simvastatina Arena 20 mg film-coated tablets (AA1161/01503)
- EMA: Cholib (fenofibrate and simvastatin), European public assessment report
- Medicines Authority: prescription-only and non-prescription medicines
- Medicines Act (Cap. 458), Article 81 (legislation.mt)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State (EUR-Lex)